Drug News
-
Global Pharmaceutical Contract Manufacturing Market Report 2023-2030
The “Global Pharmaceutical Contract Manufacturing Market – Forecast to 2030” report, recently added to ResearchAndMarkets’s offerings, provides a comprehensive analysis…
Read More » -
The Opioid Market Size to Hit $25.3 Billion by 2030
The “Opioid Market Size, Share & Trends Analysis Report” offers a comprehensive overview of the global opioid market, providing valuable…
Read More » -
Former Philippine Senator Leila de Lima Granted Bail After Seven Years Amidst Controversial “War on Drugs”
A Philippine court on Monday granted bail to Leila de Lima, a former senator and vocal critic of former President…
Read More » -
Oncology Dominates Active Pharmaceutical Ingredient CDMO Market with 35.5% Revenue Share
Oncology asserts its dominance in the Active Pharmaceutical Ingredient CDMO Market, commanding a formidable 35.5% share of the revenue. In…
Read More » -
Clinical Trial Supplies Market Projected To Grow By $1.19 Billion from 2022 to 2027
The clinical trial supplies market is poised for substantial growth, with an anticipated increase of USD 1.19 billion from 2022…
Read More » -
How Much Does a Respiratory Therapist Earn
Who is a respiratory therapist? A Respiratory Therapist (RT) is a healthcare professional who specializes in the assessment and treatment…
Read More » -
Umbilical Cord Milking Deemed Safe for Preterm Infants Born After 28 Weeks, NIH Study Finds
A recent study funded by the National Institutes of Health (NIH) has revealed that umbilical cord milking, a procedure involving…
Read More » -
3D Printing Medical Device Market to Reach $9.42 Billion by 2030 -Research
Infinium Global Research, a prominent market research firm, has unveiled an extensive report that delves deep into the 3D Printing…
Read More » -
FDA Approves Ixchiq The First Vaccine to Prevent Disease Caused by Chikungunya Virus
The U.S. Food and Drug Administration approved Ixchiq, the first chikungunya vaccine. Ixchiq is approved for individuals 18 years of…
Read More » -
FDA Approves Zepbound (tirzepatide) for Chronic Weight Management
The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and…
Read More »